Delegates by Industry
 | | | Drug Delivery 35%
| | | Specialty Pharma 17%
| | | Pharma 17%
| | | Biotechnology 8%
| | | Venture Capital/ Private Equity 5%
| | | CMO 5%
| | | Material Suppliers 4%
| | | Drug Device 4%
| | | Generics 2%
| | | Legal/Licensing 2%
| | | Academic 1% |
|
Delegates by Job Function
 | | | Business Development 40%
| | | C-level Executive 17%
| | | R&D 13%
| | | Technology Assessment 10%
| | | Product Development/LCM 9%
| | | Marketing 7%
| | | Licensing/Legal 2%
| | | Financial Analyst 2% |
|
Pharma, Specialty Pharma, Biotech, Consumer Product/OTC, and Generic Companies in the following departments:
- Business Development
- Licensing
- Technology Assessment
- Commercial Development
- Patents
- Life Cycle Management
- Strategic Planning and Development
- Financial Analyst
- Pharmaceutical and Analytical R&D
- Pharmaceutical Science
- Drug Delivery Scientists
| - Preformulation/Formulation/Stability
- Testing
- Product Development
- New Product Planning
- New Technology Evaluation
- Marketing
- Brand Management
- Product Management
- Sales
- Regulatory Affairs
|
Senior Executives at Drug Delivery companies in the following departments:
- Business Development
- Licensing
- Marketing
- Formulation Sciences
| - Technology Development
- Commercial Development
- Corporate Development
- Research & Development
|
The Event is Also of Interest to:
- Intellectual Property Attorneys
- Venture Capitalists
- Medical Device Companies
- Analysts/Investment Banks
- CROs
| - Contract Sales Organizations
- Universities and Government Research
- absHealth Plans/PBMs
- Testing and manufacturing equipment companies
- Packaging companies
|
